The Latest Cardiac and Vascular News
Two patients at MedStar Union Memorial Hospital receive recently FDA-approved Evoque Tricuspid Valve Replacements for severe tricuspid regurgitation. BALTIMORE, Jan. 24, 2025 /PRNewswire/ — In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital…
Niagara Falls, NY, Jan. 24, 2025 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical services, is pleased to announce the sale of four and rental of four NeuSight PET-CT 64-slice scanners to a prominent, established provider of advanced diagnostics and treatment for cardiovascular disease. This achievement highlights Positron’s commitment to providing innovative imaging solutions that enable healthcare providers to elevate patient care and achieve superior clinical outcomes.
CrossFAST performance exceeded expectations in ten complex high-risk coronary interventions SAN JOSE, Calif., Jan. 23, 2025 /PRNewswire/ — Vantis Vascular, Inc., a pioneering medical technology company founded by physicians with a passion to revolutionize vascular interventions, today…
– U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight system as new imaging standard in interventional cardiology- Multiple non-dilutive opportunities being pursued to fund growth TORONTO, Jan. 23, 2025 (GLOBE NEWSWIRE) — To our Shareholders, As we…
Secondary endpoints also showed a highly significant 67% reduction in major bleeding and an 89% reduction in gastrointestinal (GI) bleeding The company’s AZALEA-TIMI 71 study is the longest head-to-head study of a Factor XI inhibitor vs. a direct oral anticoagulant (DOAC) CAMBRIDGE, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Anthos Therapeutics, Inc., a transformative, clinical-stage…
January 22, 2025 06:20 AM Eastern Standard Time NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024. “2024 was a transformative year for Johnson & Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman […]
BOZEMAN, Mont., Jan. 22, 2025 /PRNewswire/ — Atrial fibrillation (AF) is the most common abnormal heart rhythm affecting 6 million people in the USA and can cause strokes and heart failure. Conventional treatments are successful but may need to be repeated, have inherent risks, and are…
MINNEAPOLIS, Jan. 21, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, today announced that it plans to release fourth quarter 2024 financial and operating results after market close on Tuesday, February…
MIAMI–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced the late-breaking data from its Nanosecond PFA 360° Cardiac Catheter System first-in-human feasibility study, which data were recently presented at the 30th Annual AF Symposium 2025 meeting. “This novel technology […]
January 21, 2025 10:10 AM Eastern Standard Time TEMPE, Ariz.–(BUSINESS WIRE)–Aptyx, a leading global developer and manufacturer of complex components and devices for the life sciences, today announced the acquisition of the Charlotte, North Carolina facility of Medical Murray, which develops and produces catheter-based interventional products and transcatheter implants. “This […]
